Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 NAD Reviews Hims & Hers Hair Loss Product Claims - Happi
Regulations

NAD Reviews Hims & Hers Hair Loss Product Claims

Recommends removing language from a comparative efficacy claim about combining finasteride and minoxidil.

Photo courtesy gguy/stock.adobe.com

The National Programs’ National Advertising Division (NAD) reviewed advertising challenged by Kenvue Inc. for four Hims & Hers compounded hair-loss products: Hims Topical Finasteride & Minoxidil Spray, Hims Topical Finasteride & Minoxidil Serum, Hers Postmenopausal Hair Loss Spray and Hers Hair Blends Postmeno Serum.

NAD recommended removing the unsupported “doctor trusted” language from a comparative efficacy claim about combining finasteride and minoxidil. It recommended that Hims & Hers:

  • Qualify “doctor-trusted ingredients” claims with the underlying dermatologist survey results and the applicable ingredients, combinations and patient populations.
  • Discontinue the claim that Hims Hair Hybrids contain “dermatologist-recommended prescription ingredients.”
  • Revise safety and side-effect claims to distinguish evidence about topical finasteride generally from evidence concerning the specific compounded products advertised.
  • Identify relevant evidence limitations and avoid suggesting that local scalp reactions are the only material risks.
  • Clearly disclose material non-local risks, where appropriate, and place safety disclosures clearly and conspicuously near the claims they qualify.

The decision reinforces that health and pharmaceutical marketers ensure claims about efficacy, expert support, safety and side effects are supported by evidence and clearly communicate important limitations and risks to consumers, said NAD.

Read the full letter here.

Upcoming Meeting

The BBB National Programs National Advertising Division Annual Conference will be held Sept. 28-29 at The Conrad New York Downtown in New York City, as reported in Happi.

Hims & Hers Expands Into GLP-1s

Besides hair loss products, the online wellness platform is also growing its portfolio to include GLP-1 products. Read about it here.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters